Chair: Asa Waldstein (Supplement Advisory Group)
Staff Contact: Jane Wilson
AHPA Members, if you would like to join this committee, please email the staff contact.
The American Herbal Products Association (AHPA) provided a letter of support to the World Anti-Doping Agency (WADA) following the September 14, 2021 announcement of WADA’s Executive Committee recommendation that a scientific review of cannabis (Cannabis sativa L.) will be undertaken by the agency in 2022.
AHPA has published an update to its Guidance on California Proposition 65 and Hemp Products to recognize the impact of the passage of California AB 45 Industrial hemp products, which was signed into law by Governor Gavin Newsome on October 6, 2021.
On September 1, 2021, AHPA submitted comments to the Senate sponsoring offices for the “Cannabis Administration and Opportunity Act” (CAOA) Discussion Draft.
On Monday August 23, 2021, AHPA submitted comments to the Oregon Liquor Control Commission (OLCC) in response to the recent enacted Emergency Rule titled “Adult Use Cannabis and Hemp Concentration Limits.”
The AHPA Board of Trustees approved two new guidance resources for the hemp industry during its meeting on Tuesday June 29, 2021. The resources are the latest guidance documents developed by AHPA’s Cannabis Committee, which was formed in 2010 to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species, including products derived from hemp as legalized under the 2018 Farm Bill.
Silver Spring, MD, May 19, 2021 – Today, Senators Ron Wyden and Jeff Merkley (D-OR) and Senator Rand Paul (R-KY) introduced bipartisan legislation that would protect public health by providing legal clarity in the hemp and hemp-derived cannabidiol (CBD) product marketplace.
The American Herbal Products Association (AHPA) has published a Hemp Lexicon intended to support the standardization of the terminology used in the cultivation, processing, manufacturing, and labeling of hemp and products derived from hemp as defined in U.S. federal law.
On February 4, 2021 Representative Kurt Schrader (D-OR) and Representative Morgan Griffith (R-VA) re-introduced bipartisan legislation that would protect public health by providing legal clarity in the cannabidiol (CBD) product marketplace. Re-introduced in the 117th Congress as HR 841, the Hemp and Hemp-derived CBD Consumer Protection and Market Stabilization Act of 2021 directs the U.S. Food and Drug Administration (FDA) to use its authority and resources to set a clear regulatory framework for hemp and hemp-derived CBD and assure consumer protection.
2022 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.